Business Wire

Nexo Championship Returns to Aberdeenshire as Nexo Expands DP World Tour Footprint

20.5.2026 17:00:00 EEST | Business Wire | Press release

Share

Nexo, the premier digital assets wealth platform, and the DP World Tour have confirmed a renewed agreement that will see the Nexo Championship return to Trump International Golf Links in Aberdeenshire from August 20-23, 2026. The tournament will serve as the concluding event of the DP World Tour’s Closing Swing – the final event of the first phase of the 2026 Race to Dubai.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520684059/en/

Nexo Championship 2026

In 2025, Nexo joined the DP World Tour as its Official Digital Wealth Platform through 2027 before soon adding the title rights at the Nexo Championship. For its part, the Nexo Championship made its mark from day one: The inaugural 2025 edition launched the Course Record presented by Nexo – a season-long rolling prize fund, starting at $10,000 per tournament and growing with each event until a course record is broken, before resetting for the next.

"The Nexo Championship has become something we are genuinely proud of – a tournament that launched the first-ever course record prize on the DP World Tour, and a Scottish champion on home soil in its inaugural year. We are back because this partnership earns its place in our portfolio through measurable long-term view. The Nexo Championship and the DP World Tour give us concentrated, recurring exposure to exactly the audience Nexo is built for – and that is a combination worth renewing,” the Nexo team said of the sponsorship.

Ben Cowen, Chief Tournament and Operations Officer at the DP World Tour, said: “We are pleased to have reached this new agreement with both Nexo and Trump International Golf Links for the Nexo Championship to again be part of our global schedule, and we thank them for their continued commitment. The Trump International Old Course has earned a reputation as one of the leading new links courses in the United Kingdom, and it was a great backdrop for last year’s tournament. With the Staysure PGA Seniors Championship taking place on our Staysure Legends Tour at the start of August, it is set to be another fantastic month of golf in Aberdeen this summer.”

Speaking on behalf of the host venue, Eric F. Trump said: “We are greatly honoured to host the DP World Tour’s Nexo Championship at Trump International, Scotland – home of the greatest 36 holes in world golf. This is the second consecutive year we have hosted this prestigious event, and I am immensely proud of the two championships link courses that we have built along the spectacular North Sea shoreline. It is testament to their quality and stature that both the Old Course and New Course will host world-class tournaments this August.”

Don Trump Jr. also commented on the renewal of the Nexo Championship: “2026 is set to be another incredible year for championship golf at Trump International, Scotland. A huge thank you to the title sponsor Nexo and all those committed to delivering this great event.”

As a tournament, the Nexo Championship first appeared on the Race to Dubai in 2020 as the Scottish Championship. Its evolution into a named Nexo staple reflects both the DP World Tour’s growing sponsorship ambitions and Nexo’s broader mission for consistent, long-term, and purposeful title partnerships at historically significant events – the most effective tools for building lasting brand recognition in premium markets.

At last year’s Nexo Championship, Scotland’s Grant Forrest claimed his second DP World Tour title, finishing eight under par and four strokes clear of England’s Joe Dean. Forrest also collected a $10,000 bonus as the inaugural winner of the Course Record presented by Nexo, set during a second-round 66. The 2026 edition will introduce a celebrity pro-am on Wednesday, August 19, broadening the tournament’s appeal beyond solely the professional field.

The Nexo Championship renewal is one expression of a deliberate, long-term approach to sport that Nexo is building across disciplines and continents. As Official Partner of the Audi Revolut Formula 1 Team, Official Crypto Partner of the Australian Open, title partner of the ATP 500 Dallas Open, and Official Regional Digital Asset Partner of the Argentine National Football Team ahead of the 2026 FIFA World Cup, Nexo has constructed a portfolio designed for compounding returns – recurring, premium exposure and experiences for the financially active, globally mobile audiences it serves.

About Nexo

Nexo is a premier digital assets wealth platform designed to empower clients to grow, manage, and preserve their crypto holdings. Our mission is to lead the next generation of wealth creation by focusing on customer success and delivering tailored solutions that build enduring value, supported by 24/7 client care.

Since 2018, Nexo has provided unmatched opportunities to forward-thinking clients in over 199+ jurisdictions. With over $430 billion processed globally, we bring lasting value to millions worldwide. Built on deep industry expertise, a sustainable business model, robust infrastructure, stringent security, Nexo champions innovation and long-lasting prosperity.

Official website: nexo.com

About the DP World Tour

The DP World Tour is the main men’s professional golf tour of the European Tour group. As golf’s global tour, we showcase global talent in global destinations and use our platform to build, entertain and connect our global community.

GLOBAL TALENT: We provide pathways and a platform for the leading international talent, bringing together golfing icons, national heroes and emerging stars from around the world.

GLOBAL DESTINATIONS: We stage tournaments in iconic cities and locations around the world and each week we celebrate and showcase the rich diversity of the courses, cities and cultures we visit.

GLOBAL COMMUNITY: We build, entertain and connect communities through our commitment to innovation, creative content and having a positive social and environmental impact.

Our 2026 Global Schedule features 42 tournaments in 25 different countries and comprises three distinct phases: five ‘Global Swings’, the ‘Back 9’ and the ‘DP World Tour Play-Offs’. It features five Rolex Series events – the premium category of events on the DP World Tour – and four Major Championships, all of which count towards the Race to Dubai Rankings, the Tour’s season-long competition which concludes at the DP World Tour Championship in Dubai.

DP World, the leading provider of global smart end-to-end supply chain and logistics solutions, has been the title partner of the DP World Tour since the start of the 2022 season, the Tour’s 50th season following its formation in 1972. We also enjoy the support of many of the world’s leading business brands with DP World, Rolex, Aldar, AWS, BMW, Buffalo Trace Distillery, Emirates, Fortinet, HCLTech, Husqvarna, Michelob ULTRA, Nexo and Vestas as Official Partners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260520684059/en/

Contacts

Media Contacts
Nexo Communications team | communications@nexo.com
DP World Tour Communications | Caitlin Nobes, cnobes@etghq.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye